Inventor · disambiguated record
Haishan Li
Also filed as: LI HAISHAN
27 granted patents·13 pending applications·273 citations·filing 2017–2025
97Inventor score
Files withAMERICAN GENE TECH INT INC36AMERICAN GENE TECH INTEMATIONAL INC1LI HAISHAN1TRAWSFYNYDD THERAPEUTICS INC1VIRIOM INC1
Top patents by PatentIndex Score
40 records- 0197US10233464B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2018·Granted Mar 19, 2019·25 cites·14 claims
- 0297US10137144B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 27, 2018·28 cites·20 claims
- 0397US10036040B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 31, 2018·30 cites·19 claims
- 0497US10036038B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 31, 2018·25 cites·18 claims
- 0597US9914938B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Mar 13, 2018·34 cites·17 claims
- 0697US9834790B1Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Dec 5, 2017·33 cites·13 claims
- 0796US10420789B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Sep 24, 2019·13 cites·20 claims
- 0896US10023880B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2017·Granted Jul 17, 2018·29 cites·11 claims
- 0995US10472649B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Nov 12, 2019·14 cites·6 claims
- 1094US11090379B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2019·Granted Aug 17, 2021·5 cites·39 claims
- 1194US10772905B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2019·Granted Sep 15, 2020·6 cites·14 claims
- 1293US10888613B2Method of producing cells resistant to HIV infectionAMERICAN GENE TECH INT INC·Filed 2017·Granted Jan 12, 2021·5 cites·12 claims
- 1393US10767183B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2017·Granted Sep 8, 2020·7 cites·24 claims
- 1493US10494647B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2018·Granted Dec 3, 2019·5 cites·17 claims
- 1592US10428350B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2018·Granted Oct 1, 2019·7 cites·16 claims
- 1691US2025121051A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
- 1789US12370253B2Pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Granted Jul 29, 2025·0 cites·10 claims
- 1888US11612649B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2021·Granted Mar 28, 2023·1 cites·94 claims
- 1988US11519006B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2019·Granted Dec 6, 2022·1 cites·16 claims
- 2088US11242527B1Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2021·Granted Feb 8, 2022·1 cites·19 claims
- 2186US11534450B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 2285US12410446B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 9, 2025·0 cites·13 claims
- 2385US2024238406A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 2484US12403155B2Methods and compositions for the activation of gamma-delta T-cellsAMERICAN GENE TECH INT INC·Filed 2022·Granted Sep 2, 2025·0 cites·16 claims
- 2584US2025121050A1Methods of producing cells resistant to hiv infectionAMERICAN GENE TECH INT INC·Filed 2024·Application pending·0 cites
- 2684US2023241200A1Hiv pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 2783US2025376685A1Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2025·Application pending·0 cites
- 2882US11911458B2HIV pre-immunization and immunotherapyAMERICAN GENE TECH INT INC·Filed 2017·Granted Feb 27, 2024·1 cites·18 claims
- 2979US12359203B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2022·Granted Jul 15, 2025·0 cites·26 claims
- 3074US2024115604A1Methods of manufacturing genetically-modified lymphocytesAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 3174US2024141374A1On demand expression of exogenous factors in lymphocytesAMERICAN GENE TECH INT INC·Filed 2023·Application pending·0 cites
- 3273US10975374B2Combination vectors and methods for treating cancerAMERICAN GENE TECH INT INC·Filed 2020·Granted Apr 13, 2021·0 cites·18 claims
- 3372US12090200B2Methods of producing cells resistant to HIV infectionAMERICAN GENE TECH INT INC·Filed 2020·Granted Sep 17, 2024·0 cites·12 claims
- 3464US2025376464A1Compounds for treatment a coronavirus infectionTRAWSFYNYDD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3563US2024279678A1On demand expression of exogenous factors in lymphocytes to treat hivAMERICAN GENE TECH INT INC·Filed 2021·Application pending·0 cites
- 3662US2021015868A1Methods of manufacturing genetically-modified lymphocytesAMERICAN GENE TECH INT INC·Filed 2019·Application pending·0 cites
- 3759US2024075140A1Engineered nk cells and methods of treating cancerAMERICAN GENE TECH INTEMATIONAL INC·Filed 2022·Application pending·0 cites
- 3858US2025332162A1Inhibiting purine biosynthesis to increase favipiravir potency against rna virus infectionsVIRIOM INC·Filed 2023·Application pending·0 cites
- 3955USD1039357SElectronic door lockLI HAISHAN·Filed 2022·Granted Aug 20, 2024·2 cites·1 claims
- 4046US2020384021A1Hiv immunotherapy with no pre-immunization stepAMERICAN GENE TECH INT INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haishan Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →